Month: December 2024

The US Food and Drug Administration (FDA) has approved the obesity treatment tirzepatide (Zepbound, Eli Lilly) for treating moderate to ...

Hospitals trial AI to spot type 2 diabetes risk

Two NHS hospital trusts in London are using AI technology to see if they can spot type 2 diabetes in ...

Why Sex and Gender Are Important Biomarkers in PsA

NEW YORK — Rheumatologists, dermatologists, drug manufacturers, and researchers do not pay enough attention to the role sex and gender ...

Slow-Paced Martial Arts Drives Sustained Activity in Older Adults

TOPLINE:Older adults with mild cognitive impairment or memory concerns increased their physical activity by an average of 65 minutes per ...

Breast Cancer Screening Shows Gaps in Women Aged 40-49 Years

TOPLINE:Among 20.1 million women aged 40-49 years, only 59.2% underwent biennial mammography screening, with significantly lower rates observed in racial ...

Q&A With NIH Dermatology Consultation Service Director

Edward W. Cowen, MD, MHSc, senior clinician at the National Institute of Arthritis and Musculoskeletal and Skin Diseases, leads the ...

Psoriasis Affects an Estimated 3% of US Adults

TOPLINE:Approximately 3% of adults in the United States have psoriasis, with a higher prevalence among older adults, individuals with overweight ...

People seek NHS advice on drinking and breastfeeding at Christmas

NHS website information on drinking while breastfeeding saw the highest increase in visits at Christmas last year, new figures show. ...

Combining Retinal Scanning and Liver Screening in T2D

TOPLINE:Simultaneous screening for liver fibrosis during retinal scanning shows promise as a novel pathway for detecting advanced liver disease in ...

AI Catches Missing MRI Lesions

LOS ANGELES — An open-source artificial intelligence (AI) module can help identify epileptic lesions on MRI missed by human reviewers, ...

New-Onset Epilepsy, Migraine Tied to Hypertensive Disorders of Pregnancy

Hypertensive disorders of pregnancy were tied to higher risks of new-onset neurologic conditions later in life.Women with eclampsia had a ...

Biomarker-Selected Treatment Shows Promise for Bladder Preservation in MIBC

Biomarker-driven treatment for muscle-invasive bladder cancer (MIBC) led to a 2-year metastasis-free survival (MFS) rate that exceeded 70% in a ...

Omitting Axillary Lymph Node Dissection in Early Breast Cancer

Recently, omission of axillary lymph node dissection among patients with early breast cancer has been found to have no detrimental ...

Abortion Opponents Shift Focus to Pills, With Lawsuits and Proposed Laws

Opponents of abortion are increasingly focusing on restricting access to pills, which are the most common way to end a ...

First Generic of Once-Daily GLP-1 Injection Approved for Diabetes

The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control in patients ...

FDA Approves Second Generic Daily GLP-1 Drug for T2D

The US Food and Drug Administration has approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor agonist (GLP-1 ...

How Cell Therapies Help Fight Solid Tumors

The cutting edge of treating solid tumors with cell therapies got notably sharper this year.First came the US Food and ...

Study Underscores Caution for NSAID Use in Pregnancy

Some gestational exposures to nonsteroidal anti-inflammatory drugs (NSAIDs) may carry more chronic kidney disease (CKD) risk for the child than ...

Specialty Board Certification Error Causes Headaches for Doctors